世界のがん遺伝子治療市場分析...市場調査レポートについてご紹介

1. Introduction to Gene Therapy
1.1 History of Gene Therapy
1.2 Vectors of Gene Therapy

2. Global Gene Therapy Market
2.1 Market Overview
2.2 Emerging Trends in Gene Therapy

3. Significance of Cancer Therapeutics in Gene Therapy

4. Current Applications of Gene Therapy to Cancer Treatment
4.1 Cancer Treatments Currently Available
4.2 Approaches to Cancer Gene Therapy
4.3 Gene Therapy Used in Cancer Treatment
4.4 Methods of Inserting Genes into Cancer Patients

5. Cancer Gene Therapy Market Dynamics
5.1 Favorable Parameters for Cancer Gene Therapy
5.2 Issued Involved with Application of Gene Therapy in Cancer Patients
5.3 Cancer Gene Therapy Clinical Insight

6. Regulatory Scenario for Gene Therapy Market
6.1 EU
6.2 US

7. Cancer Gene Therapy Drug Clinical Trial Insight by Phase, Country & Target Indications
7.1 Unknown Phase
7.2 Research
7.3 Preclinical
7.4 Phase I/II
7.5 Phase II
7.6 Phase III

8. Marketed Cancer Gene Therapy Drugs

9. Suspended & Discontinued Cancer Gene Therapy Drug Pipeline
9.1 No Development Reported
9.2 Discontinued
9.3 Suspended

10. Competitive Landscape
10.1 Advantagene
10.2 BioCancell
10.3 Celgene
10.4 Cell Genesys
10.5 Epeius Biotechnologies
10.6 GenVec
10.7 Introgen Therapeutics
10.8 MultiVir
10.9 ZIOPHARM Oncology
10.10 Shenzhen SiBiono GeneTech

Figure 3-1: Gene Therapy by Indication
Figure 5-1: Favorable Parameters for Cancer Gene Therapy
Figure 5-2: Cancer Gene Therapy Drug Clinical Pipeline by Phase (%), 2014
Figure 5-3: Cancer Gene Therapy Drug Clinical Pipeline by Phase (Number of Drugs), 2014
Figure 5-4: Suspended Cancer Gene Therapy Drug by Phase (%), 2014
Figure 5-5: Suspended Cancer Gene Therapy Drug by Phase (Number of Drugs), 2014
Figure 5-6: Discontinued Cancer Gene Therapy Drug by Phase (%), 2014
Figure 5-7: Discontinued Cancer Gene Therapy Drug by Phase (Number of Drugs), 2014
Figure 5-8: No Development Reported Cancer Gene Therapy Drug by Phase (%), 2014
Figure 5-9: No Development Reported Cancer Gene Therapy Drug by Phase (Number of
Drugs), 2014